Page 11234..1020..»

Category Archives: Cell Therapy

Best Hair Treatment | Ovation Hair Cell Protein Therapy

Posted: September 8, 2017 at 3:42 am

Recommended For You Cell Therapy Hair Treatment 12oz $56.95 New worth 9 loyalty points All Hair Types The unique micro-technology of the complex proteins in Cell Therapy penetrate the hair cortex, building strand strength from within. Continue reading

Posted in Cell Therapy | Comments Off on Best Hair Treatment | Ovation Hair Cell Protein Therapy

GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO – Drug Discovery & Development

Posted: at 3:42 am

Adaptimmune Therapeutics, a leader in T-cell therapy to treat cancer, announced thatGlaxoSmithKline plc(LSE:GSK) (NYSE:GSK) has exercised its option under a collaboration and license agreement signed in 2014 to exclusively license the right to research, develop, and commercialize Adaptimmunes NY-ESO SPEAR T-cell therapy program. Further details will be provided in a conference call scheduled for8:30 AM EDTthis morning; dial-in and webcast details are provided below Continue reading

Posted in Cell Therapy | Comments Off on GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO – Drug Discovery & Development

Cell therapy emergence opens up new markets for shippers, logistic companies – BioPharma Dive

Posted: at 3:42 am

Dive Brief: CAR-T therapy has already pushed the boundaries of what’s possible in treating patients with certain types of aggressive blood cancers that are resistant to other treatments. The remarkable clinical efficacy seen in these patients, who would otherwise have few remaining options, stoked optimism that reprogramming T-cells to target and destroy cancers could transform the standard of care. That promise has led to heavy investment from biotech and pharma companies eager to become leaders in the still-emerging cell therapy space. Continue reading

Posted in Cell Therapy | Comments Off on Cell therapy emergence opens up new markets for shippers, logistic companies – BioPharma Dive

Cellectis shares slump as death puts cell therapy tests on hold – Reuters

Posted: at 3:41 am

LONDON (Reuters) – French cell therapy specialist Cellectis, which is developing a gene-modified cancer treatment similar to Novartiss recently approved Kymriah, has been forced to suspend testing following a patient death. Cellectis said on Tuesday it was working closely with the U.S. Continue reading

Posted in Cell Therapy | Comments Off on Cellectis shares slump as death puts cell therapy tests on hold – Reuters

GE launches cell therapy thawing tech – BioPharma-Reporter.com – BioPharma-Reporter.com

Posted: at 3:41 am

GE Healthcare has launched a thawing technology for cell therapies it says removes the risks and inconsistencies of standard water baths. Water bath thawing is the most common method for thawing cell therapies, Philip Vanek, GEs general manager of Cell Therapy Growth Strategy told Biopharma-Reporter Continue reading

Posted in Cell Therapy | Comments Off on GE launches cell therapy thawing tech – BioPharma-Reporter.com – BioPharma-Reporter.com

Stem Cell Therapy: A Lethal Cure – Medical News Bulletin

Posted: at 3:41 am

Stem cell therapy is a two-step process. First, the patients blood cells are destroyed by chemotherapy, radiation therapy or immunosuppression Continue reading

Posted in Cell Therapy | Comments Off on Stem Cell Therapy: A Lethal Cure – Medical News Bulletin

Spain OKs TiGenix’s bigger cell therapy plant as firm preps for Cx601 – BioPharma-Reporter.com

Posted: at 3:41 am

Spain has licensed TiGenix NV’s expanded Madrid plant paving the way for a potential European launch of Cx601, its cell therapy forthe Crohn’s disease complications. Belgium-based TiGenix announced it received the Spanish Medicines Agency (AEMPS) license this week, explaining the Madrid plant will provide capacity for production of its portfolio of cell therapies including the candidate cell therapy Cx601. Continue reading

Posted in Cell Therapy | Comments Off on Spain OKs TiGenix’s bigger cell therapy plant as firm preps for Cx601 – BioPharma-Reporter.com

Europe’s first stem cell therapy backed by NICE – PharmaTimes

Posted: August 26, 2017 at 9:42 am

Chiesi’s Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition. The National Institute for Health and Care Excellence has now published final guidelines backing Holoclar as an option to treat adults with moderate to severe limbal stem cell deficiency (LSCD) after eye burns. Continue reading

Posted in Cell Therapy | Comments Off on Europe’s first stem cell therapy backed by NICE – PharmaTimes

WATCH: Springs Integrated Health explains the use of stem cell … – Colorado Springs Gazette

Posted: at 9:42 am

Stem cell therapy has been used for decades in Europe, and in the United States has been used by Peyton Manning, Tiger Woods, and many NFL players and other professional athletes. Although stem cells were initially reserved for the ultra wealthy, they have since become both affordable and accessible; and many patients are opting for them over lengthy and expensive knee and shoulder surgeries. One in 400 total knee replacements result in fatal infection, and those that do not end up in infection still prove to have an extensive recovery time. Continue reading

Posted in Cell Therapy | Comments Off on WATCH: Springs Integrated Health explains the use of stem cell … – Colorado Springs Gazette

Cell based therapy is gaining momentum : Dr Pradeep V Mahajan – ETHealthworld.com

Posted: at 9:42 am

Recently Dr Pradeep V Mahajan was honoured with Paris Appreciation Awards, 2017 for Excellence in stem cell therapy. He is the Chairman and Managing Director of StemRx Bioscience Solutions Pvt Ltd Continue reading

Posted in Cell Therapy | Comments Off on Cell based therapy is gaining momentum : Dr Pradeep V Mahajan – ETHealthworld.com

Page 11234..1020..»